Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Pablo Legorreta, founder and CEO of Royalty Pharma, an investment firm that acquires pharmaceutical royalty streams, has led a group of investors in founding a new company called ProKidney. After raising $75 million, ProKidney spent $62 million to acquire the cell therapy company inRegen and its manufacturing affiliate, Twin City Bio. inRegen is developing therapies for kidney diseases using stem cells obtained and isolated from a biopsy. Those cells are grown in the lab and implanted back into the damaged kidney on a hydrogel scaffold. Phase II trials are underway.
This article has been sent to the following recipient: